CORCEPT THERAPEUTICS INC (CORT) Debt Components
- 2017-12-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2017-09-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2017-06-30: Long-term Debt, Current MaturitiesUSD $4.57M; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2017-03-31: Long-term Debt, Current MaturitiesUSD $10.11M; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
CORCEPT THERAPEUTICS INC Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium), Net USD | Debt Instrument, Convertible, Interest Expense (Deprecated 2013-01-31) USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $4.57M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $10.11M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $14.66M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $18.73M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $18.56M | $3.74M | (m) | (m) | (m) | (m) | (m) | $45.00M | $1.28M | (m) |
| 2016-03-31 | $16.32M | $8.72M | (m) | (m) | (m) | (m) | (m) | $45.00M | $1.80M | (m) |
| 2015-12-31 | $14.96M | $12.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $45.00M | $2.38M | (m) |
| 2015-09-30 | $13.51M | $16.13M | (m) | (m) | (m) | (m) | (m) | $45.00M | $-3.04M | (m) |
| 2015-06-30 | $12.03M | $19.40M | (m) | (m) | (m) | (m) | (m) | $45.00M | $-3.73M | (m) |
| 2015-03-31 | $10.66M | $22.13M | (m) | (m) | (m) | (m) | (m) | $45.00M | $4.47M | (m) |
| 2014-12-31 | $9.42M | $24.46M | (m) | (m) | (m) | (m) | (m) | $45.00M | $5.23M | (m) |
| 2014-12-31 | (m) | (m) | $33.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $8.66M | $25.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $7.40M | $27.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $6.90M | $28.22M | (m) | (m) | (m) | (m) | (m) | $45.00M | $-7.87M | (m) |
| 2013-12-31 | $5.74M | $29.32M | (m) | (m) | (m) | (m) | (m) | $45.00M | $8.91M | (m) |
| 2013-09-30 | $4.50M | $30.14M | (m) | (m) | (m) | (m) | (m) | $45.00M | $-9.98M | (m) |
| 2013-06-30 | $3.65M | $30.24M | (m) | (m) | (m) | (m) | (m) | $45.00M | $11.11M | (m) |
| 2013-03-31 | $3.90M | $28.89M | (m) | (m) | (m) | (m) | (m) | $45.00M | $12.21M | (m) |
| 2012-12-31 | $2.65M | $29.03M | (m) | (m) | (m) | (m) | (m) | $45.00M | $-13.32M | (m) |
| 2012-12-31 | (m) | (m) | $45.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $2.25M | $28.32M | (m) | $4.50M | $11.25M | $14.25M | $15.00M | $45.00M | $14.43M | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 167 month · $104.00K |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 164 month · $104.00K |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 161 month · $104.00K |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 158 month · $104.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |